Nippon Kayaku Co., Ltd. (NPKYF)
POSITIVEPrice
$2130.50
Market Cap
$316.01B
Fundamental
69
Technical
75
Composite
71
AI Analysis
Generated on demand using your Gemini API key
Gemini API key not configured
Add your Gemini API key in Settings to unlock AI analysis.
Overview
Nippon Kayaku Co., Ltd. engages in mobility and imaging, fine chemicals, and life sciences businesses in Japan. The company offers airbag inflators, micro gas generators for seatbelt pretensioners and squib; and liquid crystal display (LCD) projector and display, and x-ray analysis system components. It also provides epoxy and maleimide resin, epoxy resin hardener, reactive flame retardant, acrylic acid esters, UV-curable resins for resist, resist for MEMS, cleaners for LCDs and semiconductors, and LCD sealants, as well as semiconductor manufacturing equipment, such as laminator, remover, mounter, UV irradiation equipment; colorants for inkjet printers, dyes for inkjet textile printing, inks for industrial inkjet printers, image sensor materials, dichotomous colorants for dimmable glass, near infrared absorbers, dyes for textiles and paper, colorants for resins, developers for thermal paper, and pigment derivative; and catalysts for the production of acrylic acid, acrolein, and methacrylic acid. In addition, the company offers Anti-cancer and biological drugs, cardiovascular and photodynamic diagnostic agents, in-vitro diagnostic drugs, embolization materials, pharmaceutical API and intermediates, food additives, health food ingredients, preservatives for food quality, and cleaners and disinfectants; Insecticides, herbicides, fungicides, miticides, public health insecticides, soil fumigants, and animal repellents; and engages in real estate business. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.
Balance Sheet & Liquidity
Revenue
$222.58B
Net Income
$17.51B
Free Cash Flow
$-5.48B
Total Equity
$267.53B
Total Liabilities
$105.19B
Current Ratio
3.72
Interest Coverage
91.08
Debt/EBITDA
2.90
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Fair Value Estimation
UndervaluedFair Value
$3024.32
Current Price
$2130.50
Margin of Safety
+29.6%
Fair Value Range
$1965.81 - $4082.84
Estimation Methods
Valuation Metrics
P/E Ratio
19.88
ROE
6.5%
P/B Ratio
1.27
P/FCF
-
Gross Margin
32.1%
ROIC
5.1%
Value Creation (Economic Moat)
ROIC
5.1%
WACC
6.5%
ROIC − WACC
-1.5 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Fundamental Analysis Criteria
Passed (18)
- EPS shows upward trend
- ROIC 5.1%
- Gross Margin 32.1%
- P/B Ratio 1.27
- Debt/Equity ratio
- Operating Margin 9.2%
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- ROE 9.1%
- Revenue Growth 5Y 6.9%
- Analyst Consensus 80% Buy
- Earnings Surprise avg 37.3%
- PEG Ratio 0.72
- Earnings Quality (OCF/NI) 1.46
- Share Dilution -1.5%
- Net Margin Trend 7.9% vs 2.0%
- Piotroski F-Score 8/9
Failed (5)
- EPS CAGR 1.76%
- Price CAGR 3.73%
- Positive Free Cash Flow
- Price below Graham Number
- DCF valuation (Overvalued)
Unavailable (5)
- P/FCF NaN
- Dividend Payout NaN%
- CapEx intensity
- Return on Tangible Assets
- Low reliance on intangibles
Price Chart
Technical Indicators
RSI (14)
62.11
SMA 50
$1923.10
SMA 200
$1696.67
MACD
-9.80
Volatility
2.0%
Momentum (12m)
63.7%
RSI 62.1, SMA trend bullish, momentum 63.7%.
Piotroski F-Score
Strong financial health
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Mr. Shigeyuki Kawamura | President, CEO & Director | 62 |
| Mr. Tsutomu Kawamura | General Manager of Finance & Accounting Division | - |
| Yasuhito Kato | MD of Technology & Director | 60 |
| Ichio Kohinata | General Manager of Legal Affairs Division | - |
| Shinji Inoue | Senior Executive Officer of planning, Corp. Communication & Accounting and Director | 59 |
| Makoto Takeda | MD of Human Resource & Director | 61 |
| Hiroshi Shimada | Senior MD, Head of Pharmaceuticals Group & Director | 60 |
| Hideyuki Yuya | MD & Head of Polatechno Group | - |
| Shigehide Kagaya | Head of Catalysts Group, Fine Chemicals Business Unit | - |
| Yoshiki Akatani | Managing Director of Fine Chemicals Business Area | - |
Audit Risk
1
Board Risk
9
Compensation Risk
1
Shareholder Rights Risk
2
Latest News
Recent headlines for NPKYF, sourced from Markets Gazette.